Tova Gardin, MD, MPP
Biography
As a clinician scientist with a strong interest in Psychiatry and Neurology, Tova Gardin, MD, MPP, performs basic and translational research to elucidate immunologic mechanisms of diseases at the intersection of these two fields. Her research prior to and during medical school investigated imaging biomarkers in traumatic brain injury and schizophrenia.
Upon graduating from Harvard Medical School with Honors in Research, Dr. Gardin completed a Neurology residency at Yale School of Medicine and received board certification in Neurology. During this time, she was awarded an NIH R25 Development Award to study transcriptional profiles at the single-cell level in autoimmune diseases affecting the central nervous system (CNS).
In the hopes of developing strategies to treat the many psychiatric and neurologic manifestations of immune-mediated diseases, such as multiple sclerosis and autoimmune encephalitis, in 2021, Dr. Gardin joined the Neuroscience Research Training Program (NRTP) of the Psychiatry Residency Program and the Neuroimmunology Fellowship Program at Yale School of Medicine. "I look forward to providing excellent integrated clinical care and building a translational research program that will elucidate immunologic mechanisms, as well as develop targeted CNS therapeutics," she says.
Titles
- Psychiatry Resident
Education & Training
- MDHarvard Medical School (2017)
- MPPWoodrow Wilson School of Public and International Affairs, Princeton University (2016)
- BAStern College (2010)
Additional Information
Biography
As a clinician scientist with a strong interest in Psychiatry and Neurology, Tova Gardin, MD, MPP, performs basic and translational research to elucidate immunologic mechanisms of diseases at the intersection of these two fields. Her research prior to and during medical school investigated imaging biomarkers in traumatic brain injury and schizophrenia.
Upon graduating from Harvard Medical School with Honors in Research, Dr. Gardin completed a Neurology residency at Yale School of Medicine and received board certification in Neurology. During this time, she was awarded an NIH R25 Development Award to study transcriptional profiles at the single-cell level in autoimmune diseases affecting the central nervous system (CNS).
In the hopes of developing strategies to treat the many psychiatric and neurologic manifestations of immune-mediated diseases, such as multiple sclerosis and autoimmune encephalitis, in 2021, Dr. Gardin joined the Neuroscience Research Training Program (NRTP) of the Psychiatry Residency Program and the Neuroimmunology Fellowship Program at Yale School of Medicine. "I look forward to providing excellent integrated clinical care and building a translational research program that will elucidate immunologic mechanisms, as well as develop targeted CNS therapeutics," she says.
Titles
- Psychiatry Resident
Education & Training
- MDHarvard Medical School (2017)
- MPPWoodrow Wilson School of Public and International Affairs, Princeton University (2016)
- BAStern College (2010)